BONUSCAP-ZERTIFIKAT - BIONTECH ADR Share Price

Certificat

DE000HD4E5C0

Market Closed - BOERSE MUENCHEN 20:45:58 24/05/2024 BST
126.8 EUR -1.50% Intraday chart for BONUSCAP-ZERTIFIKAT - BIONTECH ADR
Current month+14.57%
1 month+15.79%
Date Price Change
24/05/24 126.8 -1.50%
23/05/24 128.7 -3.20%
22/05/24 133 +9.65%
21/05/24 121.3 -0.44%
20/05/24 121.8 +3.01%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 08:45 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying BIONTECH SE
IssuerLogo Issuer UniCredit UniCredit
WKN HD4E5C
ISINDE000HD4E5C0
Date issued 05/04/2024
Strike 150 $
Maturity 20/12/2024 (209 Days)
Parity 1 : 1
Emission price 110.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 134.7
Lowest since issue 101.3
Spread 0.04
Spread %0.03%

Company Profile

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Sector
-
More about the company

Ratings for BioNTech SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: BioNTech SE

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
89.32 EUR
Average target price
104.7 EUR
Spread / Average Target
+17.22%
Consensus